Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Projecting individualized probabilities of lifetime all-cancer riskNeel M Butala, Noor Al-Hammadi, Asiri Ediriwickrema, et al.
Lung Cancer (Amsterdam, Netherlands)|February 11, 2026
Combination therapy with lorlatinib and mitogen-activated protein kinase pathway inhibition in previously treated ALK- or ROS1-rearranged lung cancerJaime L Schneider, Alona Muzikansky, Elizabeth Krueger, et al.
Npj Aging|May 12, 2026
Aging dictates tumor-specific genomic alterations across cancer typesIsabella N Grabski, Jaime L Schneider, Sara Hanahan, et al.
Aging Cell|January 27, 2015
Loss of hepatic chaperone-mediated autophagy accelerates proteostasis failure in agingJaime L Schneider, Joan Villarroya, Antonio Diaz-Carretero, et al.
NPJ Precision Oncology|November 4, 2023
Lorlatinib and capmatinib in a ROS1-rearranged NSCLC with MET-driven resistance: tumor response and evolutionJaime L Schneider, Khvaramze Shaverdashvili, Mari Mino-Kenudson, et al.
JTO Clinical and Research Reports|July 11, 2022
A Phase 2 Study of Lorlatinib in Patients With ROS1-Rearranged Lung Cancer With Brain-Only Progression on CrizotinibJaime L Schneider, Alona Muzikansky, Jessica J Lin, et al.
Nature Communications|February 19, 2025
Mass spectrometry methods and mathematical PK/PD model for decision tree-guided covalent drug developmentMd Amin Hossain, Rutali R Brahme, Brandon C Miller, et al.
JTO Clinical and Research Reports|September 30, 2021
Response to Immune Checkpoint Inhibition as Monotherapy or in Combination With Chemotherapy in Metastatic ROS1-Rearranged Lung CancersNoura J Choudhury, Jaime L Schneider, Tejas Patil, et al.
Cell|February 7, 2025
GUK1 activation is a metabolic liability in lung cancerJaime L Schneider, Kiran Kurmi, Yutong Dai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2020
Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal CancersAparna R Parikh, Amikasra Mojtahed, Jaime L Schneider, et al.
Pageof 2